Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:22:18.103Z.
Calculation as of: 2026-10-06T18:22:18.103Z.
Quote observation: 2026-10-06T18:20:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b626f321e8bf7fc1aa576344fb562ad2ba7a1b85fa36d8388ebfe6a76482c652
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
NewGenIvf Group Limited
Market Cap
$6102.00
EV/EBIT Ratio
N/A
Market Cap
$30251.00
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6102.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30251.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61495.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71110.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108729.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
